Nasdaq agrx.
PRINCETON, N.J., April 30, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that a post hoc analysis of the Phase 3 SECURE Trial ...Nov 10, 2023 · Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58. Nov 10, 2023 · 10 Best Penny Stocks to Buy in July Agile Therapeutics, Inc. (NASDAQ:AGRX) Q1 2023 Earnings Call Transcript 5 Cheap Pharmaceutical Stocks For 2022 5 Best Penny Stocks to Buy and Hold According to ... Oct 21, 2022 · NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022 Published. Oct 21, 2022 11:00am EDT. Benzinga Digital Content Studio--News Direct--Contact Details. PRINCETON, N.J., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare company, today announced that on January 9, 2019 it received final meeting ...
Agile Therapeutics, Inc. Common Stock (AGRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
PRINCETON, N.J., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the pricing of its underwritten public offering of ...Agile Therapeutics, Inc. (AGRX.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Agile Therapeutics, Inc. | Nasdaq: AGRX ...
PRINCETON, N.J., March 15, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women's healthcare company, today announced that an abstract presenting data from two Phase 1 in ...Aug 9, 2023 · PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today reported financial results for the three months ended June 30 ... Sep 27, 2023 · Maxim Group, a major investment bank, conducts and publishes stock analysis through its Equity Research team. The team has a strong reputation in the industry; a host of major firms use its ... Find the latest Revenue & EPS data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.
Find the latest Earnings Report Date for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.
PRINCETON, N.J., June 23, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today praised the Executive Order issued by President Biden that ...
James Tursi, M.D. Resigns from Board of Directors. PRINCETON, N.J., Oct. 07, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it ...Apr 26, 2023 · PRINCETON, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it has received a notification letter from the ... Agile Therapeutics, Inc. (NASDAQ:AGRX) announced its earnings results on Tuesday, November, 2nd. The specialty pharmaceutical company reported ($7.20) EPS for the quarter, beating analysts' consensus estimates of ($7.60) by $0.40. The specialty pharmaceutical company earned $1.29 million during the quarter, compared to analysts' expectations of ...Company Plans to Appeal to the FDA’s Office of New Drugs. PRINCETON, N.J., July 24, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) (the “Company”), a women’s healthcare ...View live Agile Therapeutics, Inc. chart to track its stock's price action. Find market predictions, AGRX financials and market news.PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile” or the “Company”), a women's healthcare company, today announced that it has received written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) granting the Company’s request for a 180 …
A. The latest price target for Agile Therapeutics ( NASDAQ: AGRX) was reported by Maxim Group on Friday, September 22, 2023. The analyst firm set a price …Nov 10, 2023 · Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58. PRINCETON, N.J., May 08, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report first quarter 2023 financial results after ...Company now focused on completing plan to resubmit NDA in first half of 2019. PRINCETON, N.J., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare ...PRINCETON, N.J., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's healthcare company, today reported financial results for the three and nine months ended ...PRINCETON, N.J., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced a partnership with Pandia Health, an online telehealth ...
Shares of NASDAQ AGRX opened at $2.16 on Friday. The firm has a market capitalization of $5.42 million, a PE ratio of -0.16 and a beta of 1.81. The firm’s 50-day moving average is $1.99 and its ...Agile Therapeutics Inc (NASDAQ:AGRX) Agile Therapeutics Inc. 1.90. Delayed Data. As of Nov 14. -0.02 / -1.04%. Today’s Change. 1.65. Today ||| 52-Week Range.
The Nasdaq Composite was lagging behind the other major stock indexes on Thursday as bond yields turned higher. The Nasdaq was down 0.3%, while the S&P 500 …Agile Therapeutics, Inc. (NASDAQ:AGRX) announced its earnings results on Tuesday, November, 2nd. The specialty pharmaceutical company reported ($7.20) EPS for the quarter, beating analysts' consensus estimates of ($7.60) by $0.40. The specialty pharmaceutical company earned $1.29 million during the quarter, compared to analysts' expectations of ...The purchase of more than 5.73 million Agile Therapeutics Inc (NASDAQ:AGRX) shares by a beneficial owner at about $0.85 apiece totaled over $4.87 million. The owner's stake in this contraceptives ...PRINCETON, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the pricing of its ...Follow. add_box. ... PRINCETON, N.J., May 17, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced that Al Altomari, Chairman and Chief ...We closed out the fourth quarter 2021 with a net loss of $23.4 million or $0.20 per share compared to the net loss of $17.6 million or $0.20 per share for the comparable period in 2020. The full ...Agile Therapeutics Inc Follow Share $2.06 Nov 27, 1:01:11 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Amarin Corporation plc $0.76 AMRN2.89% Apple Inc $190.63 AAPL0.34% Actinium...PRINCETON, N.J., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it intends to offer and sell shares of its common ...
5 Cheap Pharmaceutical Stocks For 2022 Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2022 Earnings Call Transcript. 5 Best Penny Stocks to Buy and Hold According to Reddit 10 Best Penny Stocks to Buy ...
AGRX | Complete Agile Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Agile Therapeutics Inc (NASDAQ:AGRX) ... Institutional investors purchased a net $3.4 thousand shares of AGRX during the quarter ended June 2019 and now own 7.67% ...Agile Therapeutics (AGRX – Research Report) received a Hold rating and price target from Maxim Group analyst Naz Rahman yesterday. The c... Agile Therapeutics (AGRX – Research Report) received a Hold rating and price target from Max...PRINCETON, N.J., March 14, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced that it has ...Shares of NASDAQ AGRX opened at $2.16 on Friday. The firm has a market capitalization of $5.42 million, a PE ratio of -0.16 and a beta of 1.81. The firm’s 50-day moving average is $1.99 and its ...Agile Therapeutics, Inc. (NASDAQ:AGRX) is a New Jersey-based healthcare company focused on catering to the unmet demands of women by offering them various contraceptive options.PRINCETON, N.J., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare company, today announced that on January 9, 2019 it received final meeting ...Agile Therapeutics Inc. (AGRX) is down over 4% at $2.74 in pre-market hours Monday on no news. The company's birth control patch Twirla is expected to be launched this quarter.PRINCETON, N.J., July 12, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced that it has updated its second quarter 2022 Twirla demand (total ...
Mar 27, 2023 · March 26, 2023 at 11:25 PM · 10 min read. Agile Therapeutics, Inc. (NASDAQ: AGRX) Q4 2022 Earnings Call Transcript March 24, 2023. Operator: Good afternoon and welcome to the Agile Therapeutics ... PRINCETON, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today applauded House Congressional Committee leaders in urging the ...Agile Therapeutics, Inc. Common Stock (AGRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. PRINCETON, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report second quarter 2022 financial results after ...Instagram:https://instagram. uber signagepfizer stock historymutf fsmdxeps apple Apr 9, 2021 · On Mar. 31, he reported buying 10,000 shares at an average price of $20.17. This case of insider buying is a personal investment of over $200,000. Wall Street also thinks that the shares are ... fastnal stockhigh leverage brokers Find the latest press releases from Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com. how to earn money in forex PRINCETON, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three months ended March 31, 2023 ...The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”